CAR-T Cell Therapy Market to Reach US$ 10.13 Billion by 2030, Growing at a CAGR of 17.5%
The CAR-T Cell Therapy Market is experiencing remarkable growth as advanced immunotherapy solutions continue to transform cancer treatment worldwide. Chimeric Antigen Receptor T-cell therapy has emerged as one of the most innovative approaches in oncology, offering personalized treatment options for patients with certain blood cancers. Rising incidences of leukemia, lymphoma, and multiple...
0 Comments
0 Shares